Efficacy and Safety of Topical GT20029 in Male Patients With Androgenetic Alopecia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study

December 2025 in “ Journal of Dermatological Treatment ”

Ruiming Hu, Aihua Wei, Liming Wu, Bin Yang, Ji Li, Linfeng Li, Yi Zhao, Chunjun Yang, Guoqiang Zhang, Yu-mei Li, Jianji Wan, Huiping Wang, Meiyu Wang, Xiang Ni, Youzhi Tong, Qinping Yang

GT20029 androgenetic alopecia topical treatment AGA

TLDR GT20029 helps regrow hair in men with hair loss and is well-tolerated.

Topical GT20029 showed significant efficacy in promoting hair regrowth in male patients with androgenetic alopecia (AGA) while maintaining good tolerability. The study suggests that GT20029 could be a promising treatment for AGA, but further research is needed to confirm its therapeutic potential.

View this study on tandfonline.com →

Discuss this study in the Community →

Research cited in this study

5 / 5 results

research Hair Regrowth Treatment Efficacy and Resistance in Androgenetic Alopecia: A Systematic Review and Continuous Bayesian Network Meta-Analysis

January 2023 in “Frontiers in Medicine”

ALRV5XR is the most effective hair regrowth treatment at 24 weeks.

Dihydrotestosterone-Induced Hair Regrowth Inhibition by Activating Androgen Receptor in C57BL6 Mice Simulates Androgenetic Alopecia

research Dihydrotestosterone-Induced Hair Regrowth Inhibition by Activating Androgen Receptor in C57BL6 Mice Simulates Androgenetic Alopecia

23 citations , January 2021 in “Biomedicine & Pharmacotherapy”

DHT stops hair regrowth in mice, similar to human hair loss.

research Cause of Androgenic Alopecia

17 citations , October 2013 in “Plastic and reconstructive surgery. Global open”

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

research Androgen Actions on the Human Hair Follicle: Perspectives

115 citations , September 2012 in “Experimental Dermatology”

Androgens have complex effects on hair growth, promoting it in some areas but causing hair loss in others, and our understanding of this is still evolving.

research The Role of Androgen and Androgen Receptor in Skin-Related Disorders

124 citations , July 2012 in “Archives of Dermatological Research”

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.

Similar Research

5 / 11 results

Topical Solutions for Androgenetic Alopecia: Evaluating Efficacy and Safety

research Recent Advances in Drug Development for Hair Loss

April 2025 in “International Journal of Molecular Sciences”

New treatments for hair loss show promise with advanced therapies and better targeting.

research Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One

10 citations , July 2022 in “Journal of Medicinal Chemistry”

Adding a second method to PROTACs could improve cancer treatment.

Efficacy and Safety of Topical GT20029 in Male Patients With Androgenetic Alopecia: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Study

Research cited in this study

research Hair Regrowth Treatment Efficacy and Resistance in Androgenetic Alopecia: A Systematic Review and Continuous Bayesian Network Meta-Analysis

research Dihydrotestosterone-Induced Hair Regrowth Inhibition by Activating Androgen Receptor in C57BL6 Mice Simulates Androgenetic Alopecia

research Cause of Androgenic Alopecia

research Androgen Actions on the Human Hair Follicle: Perspectives

research The Role of Androgen and Androgen Receptor in Skin-Related Disorders

Related Community Posts Join

community A concern regarding the upcoming androgen degrader drug GT20029

community The Cure isn't 5 years away; it's already here.

community Boys I am just a gonner. What on earth is my scalp even going through. Looks like world war 3. Pyril 3 months. Topical melitonin/progesterone/fin, dut, fin, oral min, laser trash, anus stimulation. Nothing. Donor area is decimated 😂.

community Reminder that Kintors Pyrilutamide results will be out this month

community Breezula 6 Month Topline Phase III Results Released

community PP405 Drug in Action: Picture From Official Company Website

Similar Research

research Topical Solutions for Androgenetic Alopecia: Evaluating Efficacy and Safety

research Androgens and Androgen Receptor in the Management of Skin Diseases

research The 100 Most Cited Articles in Androgenetic Alopecia: A Bibliometric Analysis

research Recent Advances in Drug Development for Hair Loss

research Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One